PEAK6 Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PEAK6 Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,500	Closed	-$932K	–	5354
2018 Q1	$932K	Hold	11,500	–	–	﹤0.01%	2035
2017 Q4	$906K	Buy	+11,500	New	+$956K	﹤0.01%	2005
2017 Q2	–	Sell	-8,500	Closed	-$851K	–	5377
2017 Q1	$851K	Sell	8,500 -27,400	-76%	-$2.93M	0.01%	1821
2016 Q4	$3.86M	Sell	35,900 -30,600	-46%	-$3.58M	0.03%	857
2016 Q3	$8.28M	Buy	66,500 +14,000	+27%	+$1.65M	0.06%	434
2016 Q2	$5.58M	Buy	+52,500	New	+$6.1M	0.04%	610
2015 Q4	–	Sell	-14,800	Closed	-$1.33M	–	5699
2015 Q3	$1.33M	Sell	14,800 -48,400	-77%	-$5.11M	0.01%	1931
2015 Q2	$7.28M	Buy	63,200 +49,300	+355%	+$5.18M	0.04%	604
2015 Q1	$1.33M	Buy	+13,900	New	+$1.04M	0.01%	1604

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PEAK6 Group's CBPO Position: Q2 2018 in Review

PEAK6 Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 4,263 shares — an estimated $345K sold.

PEAK6 Group first reported a position in CBPO in Q3 2015 and held it in 7 quarters. The position peaked at $7.76M in Q3 2016. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

PEAK6 Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
PEAK6 Group sold 4,263 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $345K.
PEAK6 Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 7 quarters.
PEAK6 Group's China Biologic Products Holdings, Inc. position peaked at $7.76M in Q3 2016.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.